BSECompany Update▼ NegativeResults11 Aug 2026
Transgene Biotek Ltd
Newspaper Publication
Transgene Biotek Ltd published unaudited financial results for the quarter ending June 30, 2026, in newspapers. The results show a net loss of Rs. 38.90 crore, compared to a loss of Rs. 43.37 crore in the same quarter last year. The company's net loss before tax and interest is Rs. 165.29 crore, compared to a loss of Rs. 165.29 crore in the same quarter last year. The company has taken possession of a property bearing No. 468/1, Ward No. 3, D No. 3/85, Ward 3, Eswarreddy Nagar Somulavari Palli Grama Panchayath & Village, Proddatur Mandal, Cuddapah Dist, AP State, measuring 127.77 square yards or 1149.93 SFT, situated at Somulavari Palli Village and Grama Panchayath, Proddatur Caddapah Dist, AP State.
BSEResultResults7 Aug 2026
Transgene Biotek Ltd
Unaudited Financial Results for the quarter ended 30th June 2026.
Transgene Biotek Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, with a net loss of Rs. 38.90 lakhs. The company's revenue from operations was Rs. 6.00 lakhs, while its expenses were Rs. 44.90 lakhs. The company has also announced the appointment of M/s. Manisha Dubey & Associates as its internal auditors for the financial year 2026-27.
BSEBoard MeetingResults7 Aug 2026
Transgene Biotek Ltd
Sub: Outcome of the Meeting of the Board of Directors held on August 07, 2026.
This has reference to our letter dated 22nd July 2026, Intimating the meeting of the Board of Directors of ....
Transgene Biotek Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, showing a net loss of Rs. 38.90 lakhs. The company has also approved the appointment of M/s. Manisha Dubey & Associates as its internal auditors for the financial year 2026-27.
BSEBoard MeetingResults23 Jul 2026
Transgene Biotek Ltd
Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Transgene Biotek Ltd has scheduled a board meeting on August 7, 2026, to consider and approve the audited financial results for the quarter ended June 30, 2026, and other matters.
BSEOthers22 Jul 2026
Transgene Biotek Ltd
Compliance - 57(4)
Transgene Biotek Ltd has informed that Regulation 57 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable to the company as there are no non-convertible securities with interest/dividend/principal payable during the quarter ended 30.06.2026.
BSECompany Update22 Jul 2026
Transgene Biotek Ltd
Statement of Deviation & Variation
Transgene Biotek Ltd has submitted a statement of deviation and variation for the quarter ended June 30, 2026, stating that no public issue, rights issue, or preferential issue occurred during the period, making the submission of the statement not applicable.
BSEOthers22 Jul 2026
Transgene Biotek Ltd
Compliance -57 (5)
Transgene Biotek Ltd has informed that Regulation 57(5) of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended June 30, 2026, as no non-convertible securities were issued.